To follow up the acclaimed 'Mare of Easttown,' Ingelsby writes for The Envelope, he looked to two men of the cloth with divergent views of faith and doubt.

Getting to a $2 trillion market cap from Eli Lilly’s current levels would require a compound annual growth rate of about 11.7% over the next seven years. That’s no easy feat, but if Eli Lilly can pull ...

The bestselling author, 27, went from a G-cup size down to a B-cup size between the ages of 20 and 22 Cindy Ord/WireImage In a TikTok posted on May 7, Eli Rallo recalled how someone recently commented ...

The influencer, 27, said she underwent two breast reductions between the ages of 20 and 22, bringing her from a G-cup size down to a B-cup size She also noted that the surgery was covered by insurance ...

There's no question that Eli Lilly is doing very well as a business right now. The company's GLP-1 weight loss drugs are growing at a shocking rate. In the first quarter of 2026, sales of Mounjaro and ...

Gambling content 21+. The New York Post may receive an affiliate commission if you sign up through our links. Read our editorial standards for more information. FanDuel CEO Amy Howe has been shown the ...

LEBANON, Ind. — Officials with Eli Lilly and Company announced an additional $4.5 billion investment in two of its three sites in Lebanon on Wednesday. According to a news release from the company, ...

The Howe Writing Center is pleased to announce the winners of their Spring 2026 Creative Writing Contests. The first invited writers to write a flash fiction story ...

Newcastle are 13th in the Premier League after Saturday's win over Brighton & Hove Albion Stu Forster/Getty Images Eddie Howe is set to remain Newcastle United head coach beyond the current season.

Eli Lilly’s latest attempt to strengthen its genetic medicine offering has seen the Big Pharma team up with Profluent to develop AI-designed recombinases to address diseases with severe unmet needs.

Eli Lilly LLY-0.00%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...